Earnings Reported After The Bell May.12

(RTTNews) - 1.Invitae Corporation(NVTA)

Q1 net loss was $18.64 million or $1.09 per share vs net loss of $9.03 million or $12.06 per share a year ago.

Q1 revenue was $1.2 million vs $118000 a year ago.

***

2. InfuSystem Holdings, Inc. (INFU)

Q1 net loss was $0.4 million, or $0.02 per share, compared to income of $0.6 million, or $0.03 per share, in the same prior year period.

Q1 Adjusted net income was $0.7 million, or $0.03 per share,same as the prior year period; Consensus $0.06.

Q1 Net Revenues was $16.7 million versus $17.2 million a year ago.

***

3.Xenon Pharmaceuticals Inc. (XENE)

Q1 Net loss was $4.2 million or $0.30 per share compared to net income of nil for the same period in 2014.

Q1 revenue was $4.0 million, compared to $5.0 million for the same period last year.

***

4.Zafgen, Inc. (ZFGN)

The company reported a net loss for the first quarter of 2015 was $13.5 million, or $0.53 per share, compared to a $4.5 million net loss, or $6.18 per share, for the first quarter of 2014.

***

5.Opexa Therapeutics, Inc. (OPXA)

Q1 net loss was $3.35 million or $.12 loss per share compared with a net loss of $3.66 million or $.13 loss per share a year ago.

Q1 total revenues were $377,543 vs $348,837 a year ago.

***

6. NV5 Holdings, Inc. (NVEE)

Net income for the first quarter of 2015 was $1.1 million or $0.18 per share, up from a net income of $707,000, or $0.13 per share in the first quarter of 2014.

First quarter revenues Increased 54% to $29.2 million from $19.0 million a year ago.

Analysts expected the company to report net income of $0.20 per share on revenues of $30.4 million for the period.

FY Outlook

The company is raising its guidance for full-year 2015 gross revenues and earnings per share.

The company now expects full-year 2015 gross revenues to range from $127 million to $137 million.

The company further expects that full-year 2015 earnings per share will range from $1.05 per share to $1.15 per share.

Analysts expect the company to report net income of $1.12 per share on revenues of $139.2 million for the period.

***

7.Civitas Solutions, Inc. (CIVI)

Net income from continuing operations for the second quarter was $1.77 million or $0.05 per share compared to a net loss of $12.24 million or $0.48 per share for the same period of the prior year.

Net revenue for the second quarter was $335.2 million, an increase of 9.4%, from $306.37 million for the same period of the prior year.

Analysts expected the company to report net income of $0.13 per share on revenues of $334.79 million for the period.

FY Outlook

Net revenue to be in the range of $1.345 billion to $1.385 billion; Consensus $1.37 billion.

***

8.Transition Therapeutics Inc. (TTHI)

Q3 net loss was $4.75 million or $0.13 per share compared to a net loss of $5.07 million or $0.17 per share a year ago.

***

9.Nova Measuring Instruments Ltd. (NVMI)

Q1 net income was $2.98 million or $0.11 per share vs $6.4 million or $0.23 per share a year ago.

Q1 Non-GAAP net income was $4.0 million, or $0.15 per share vs $6.93 million or $0.25 per share a year ago.

Q1 Revenues were $27.5 million vs $34.66 million a year ago.

***

10.PDI, Inc. ( PDII)

Q1 Loss from continuing operations was $3.74 million or $0.25 per share vs loss from continuing operations of $497000 or $0.03 per share a year ago.

Net revenue for the first quarter of 2015 was $38.3 million, an increase of 20% over $31.8 million in the first quarter of 2014.

FY Outlook

Total net revenue to be in the range of $136 million to $140 million

***

11.Foamix Pharmaceuticals Ltd. (FOMX)

Q1 Net loss was $3.1 million or $0.14 per share compared with $41,000 or $0.00 per share a year ago. Q1 Revenues were $448,000 compared with $1.4 million a year ago.

***

12.Otonomy, Inc. (OTIC)

Net loss for the first quarter of 2015 was $12.0 million or $0.52 per share compared to net loss of $10.8 million or $129.52 per share for the first quarter of 2014.

***

13.Vital Therapies, Inc. (VTL)

Q1 net loss attributable to common stockholders was $14.8 million or $0.62 per share compared with net loss attributable to common stockholders of $13.8 million or $24.49 per share for the same prior year period.

***

14.Capricor Therapeutics, Inc. (CAPR)

Q1 net loss was $3.48 million, or $0.23 per share, compared to a net loss of $1.21 million, or $0.10 per share, for the same period in the prior year.

Q1 total income was $1.79 million vs $1.04 million a year ago.

***

15.Cara Therapeutics, Inc. (CARA)

Net loss was $4.7 million, or $0.21 per share, for the first quarter of 2015, compared to net loss of $3.4 million, or $0.22 per share for the same period of 2014.

Collaborative revenue was $489,000 for the first quarter of 2015, compared to $151,000 for the same period of 2014.

***

16. Hortonworks, Inc. (HDP)

GAAP net loss for the first quarter was $40.1 million or $0.97 per share, compared to a GAAP net loss of $20.3 million or $5.25 per share a year ago.

Non-GAAP net loss for the first quarter was $32.0 million or $0.77 per share, compared to a net loss of $15.7 million or $4.08 per share in the same period last year.

Q1 Total GAAP revenue was $22.8 million, an increase of 167% compared to $8.54 million a year ago.

Analysts expected the company to report net loss of $0.86 per share on revenues of $18.22 million for the period.

Q2 Outlook

Total revenue to be between $22.5 million and $23.5 million; Consensus $20.31 million.

FY Outlook

Total revenue to be between $94.0 million and $97.0 million; Consensus $85.67 million.

***

17.Electro Scientific Industries, Inc. (ESIO)

Q4 GAAP net loss was $15.1 million or $0.48 per share vs net loss of $27.63 million or $0.92 per share a year ago.

Non-GAAP fourth quarter net loss was $6.5 million or $0.21 per share.

Revenue in the fourth quarter was $37.6 million, compared to $37.1 million in the fourth quarter of last fiscal year.

Q1 Outlook

Revenues for the first quarter of fiscal 2016 are expected to be in the $40 million range.

Non-GAAP loss per share is expected to be in the range of $0.15 to $0.20.

***

18.Ducommun Incorporated (DCO)

The net loss for the first quarter of 2015 was $2.0 million, or $0.18 per share compared to net income of $5.2 million, or $0.46 per share, for the first quarter of 2014.

Net revenue for the first quarter of 2015 was $172.9 million compared to $179.8 million for the first quarter of 2014.

***

19. ImmuCell Corporation (ICCC)

First quarter 2015 net income was $479,000, or $0.15 per share, vs net loss of ($13,000) or $0.00 per share during first quarter 2014.

Q1 Total sales increased 49% to $3.10 million from $2.08 million a year ago.

***

20.Opower (OPWR)

Q1 GAAP net loss was $(11.0) million, compared to a net loss of $(7.0) million a year ago.

Q1 GAAP net loss per share was $(0.22),compared to a GAAP net loss per share of $(0.32) a year ago.

Q1 Non-GAAP net loss was $(6.0) million, compared to a non-GAAP net loss of $(5.3) million a year ago.

Q1 Non-GAAP net loss per share was $(0.12) compared to a non-GAAP net loss per share of $(0.13) a year ago.

Total revenue for the first quarter 2015 was $33.4 million, an increase of 17% from the comparable period in 2014.

Q2 Outlook

Revenue to be in the range of 34.8 million -35.5 million.

Non-GAAP net loss per share to be in the range of (0.17)-(0.15)

FY Outlook

Revenue to be in the range of 144.0 million -149.0 million.

Non-GAAP net loss per share to be in the range of (0.68)-(0.58).

***

21.New Relic, Inc. (NEWR)

Q4 net loss was $14.83 million or $0.32 per share vs net loss of $9.76 million or $0.62 per share a year ago.

Q4 Non-GAAP net loss per share was $0.22 compared with non-GAAP net loss per share of $0.18 for the fourth quarter of fiscal 2014.

Q4 Revenue was $33.4 million, up 68% compared with the year-ago period.

Q1 Outlook

Revenue to be between $34.5 million and $35.5 million

Non-GAAP net loss per share to be between $0.23 and $0.26.

FY Outlook

Revenue to be between $155.0 million and $159.0 million

Non-GAAP net loss per share to be between $0.95 and $1.03.

***

22.Rentrak Corporation (RENT)

Total company revenue grew to $28.5 million for the fourth quarter of fiscal 2015, a 32 percent increase from $21.6 million for the fourth quarter of fiscal 2014; Consensus $30.29 million.

***

23.GoDaddy Inc. (GDDY)

Net loss for the first quarter was $43.4 million or $0.34 per share, compared to a net loss of $51.3 million or $0.40 per share for the year-ago quarter.

Revenue for the first quarter rose 17.5% to $376.3 million from $320.2 million a year ago.

Analysts polled by Thomson Reuters expected the company to earn $0.35 per share on revenue of $374.52 million for the first quarter. Analysts' estimates typically exclude special items.

Looking forward, the company forecasts revenue of $390 million to $395 million for the second quarter and $1.595 billion to $1.605 billion for the full year 2015. Analysts curently expect the company to post revenue of $390.66 million for the second quarter and $1.59 billion for the full year 2015.

***

24.Exar Corporation ( EXAR)

Q4 net loss was $2.91 million or $0.06 per share vs net income of $147000 or $0.00 per share a year ago.

Q4 non-GAAP net income was $5.64 million or $0.11 per share vs 676000 or $0.01 per share a year ago.

For the fourth fiscal quarter, the company reported revenue of $43.9 million, an increase of 57% versus $27.99 million in the prior year.

Analysts expected the company to report net income of $0.11 per share on revenues of $45.88 million for the period.

***

25.Cyclacel Pharmaceuticals, Inc. (CYCC)

The company's net loss applicable to common shareholders for the first quarter was $5.0 million, or $0.19 per share, compared to net loss applicable to common shareholders of $4.9 million, or $0.25 per share a year ago.

Q1 Revenue was $0.5 million compared to $0.4 million for the same period of the previous year.

***

26. Inogen, Inc. (INGN)

Q1 net income increased 77.0% to $1.57 million or $0.08 per share from $0.9 million or $0.01 per share a year ago.

Q1 non-GAAP net income was $1.57 million or $0.08 per share vs $888000 or 40.05 per share a year ago.

Q1 Total revenue rose 42.8% to $33.8 million, from $23.6 million a year ago.

FY Outlook

Revenue to be in the range of $133 million to $137 million.

***

27. Lumenis Ltd. (LMNS)

First quarter 2015 GAAP net income was $1.6 million or $0.05 per share compared to a net loss of $3.1 million or $0.10 per share last year.

First quarter 2015 Non-GAAP net income was $2.3 million or $0.06 per share compared to $2.2 million or $0.07 per share last year.

Total revenue in the first quarter of 2015 was $68.5 million, an increase of 4.1% compared to $65.8 million last year.

Analysts expected the company to report net income of $0.11 per share on revenues of $68.36 million for the period.

FY Outlook

Revenue to be in the range of $305 million to $310 million

Non-GAAP EPS to be in the range of $0.62 to $0.66.

Analysts expect the company to report net income of $0.64 per share on revenues of $305.75 million for the period.

***

28.CareDx, Inc. (CDNA)

For the first quarter of 2015, net loss was $2.3 million compared to a loss of $1.3 million in the first quarter of 2014.

Net loss per share was $0.19 in the first quarter of 2015, compared to $1.29 in the first quarter of 2014.

Q1 Revenue increased 22% to $7.2 million, from $5.9 million in the same period in 2014.

FY Outlook

CareDx confirmed revenue for the full year of 2015 is expected to be in the range of $28 to $30 million.

***

29.ynthesis Energy Systems, Inc. (SYMX)

The net loss attributable to stockholders for the third quarter was $4.0 million, or $0.05 per share, versus a loss of $4.2 million, or $0.06 per share, for the prior year's third quarter.

The company reported $2.8 million of revenue for Q3 versus $7.2 million a year ago.

***

30.Gevo, Inc. (GEVO)

The net loss for the first quarter of 2015 was $7.3 million or $0.88 per share compared to $12.0 million or $2.65 per share during the same period in 2014.

Revenues for the first quarter of 2015 were $5.9 million compared to $0.9 million in the same period in 2014.

***

31.EDAP TMS SA (EDAP)

Net loss for the first quarter 2015 was EUR 2.4 million (USD 2.7 million), or EUR 0.10 per share, as compared to net income of EUR 840,000 (USD 1.1 million), or EUR 0.04 per share, in the year ago period.

Q1 revenues were EUR 6.22 million vs EUR 7.77 million a year ago.

***

32.Biocept, Inc. (BIOC)

Net loss for the first quarter of 2015 was $3.8 million, or $0.37 per share vs net loss of $5.1 million, or $1.96 per share a year ago.

Revenues for the first quarter of 2015 increased to $150,000 from $28,000 for the first quarter of 2014.

***

33.Vitae Pharmaceuticals, Inc. (VTAE)

Q1 net loss was $9.71 million or $0.47 per share vs net loss of $4.89 million or $8.24 per share a year ago.

Q1 revenue was $150,239 vs $1.17 million a year ago.

***

34.Five9, Inc. (FIVN)

GAAP net loss for the first quarter of 2015 was $(8.9) million, or $(0.18) per share, compared to a GAAP net loss of $(8.3) million, or $(1.48) per share, for the first quarter of 2014. Non-GAAP net loss for the first quarter of 2015 was $(5.9) million, or $(0.12) per share, compared to a non-GAAP net loss of $(8.7) million, or $(1.55) per share, for the first quarter of 2014.

Total revenue for the first quarter of 2015 increased 25% to $30.3 million compared to $24.3 million for the first quarter of 2014.

Q2 Outlook

Revenue to be in the range of $28.7 to $29.7 million

GAAP net loss to be in the range of $(10.0) to $(11.0) million or $(0.20) to $(0.22) per share

Non-GAAP net loss to be in the range of $(7.6) to $(8.6) million or $(0.15) to $(0.17) per share

FY Outlook

Revenue to be in the range of $120.0 to $124.0 million, up from the guidance range of $117.0 to $122.0 million

GAAP net loss to be in the range of $(34.7) to $(37.7) million or $(0.69) to $(0.75) per share, improved from the guidance range of $(37.1) to $(40.1) million or $(0.73) to $(0.79) per share

Non-GAAP net loss to be in the range of $(24.4) to $(27.4) million or $(0.49) to $(0.54) per share, improved from the guidance range of $(27.4) to $(30.4) million or $(0.54) to $(0.60) per share.

***

35.Agile Therapeutics, Inc. (AGRX)

Q1 Net loss was $8.5 million, or $0.40 per share compared to net income of $0.8 million, or $0.01 per share a year ago.

***

36.McKesson Corp (MCK)

Fourth-quarter net earnings were $132 million or $0.56 per share, compared with $370 million or $1.58 per share last year.

Excluding items, adjusted earnings for the quarter were $2.94 per share, compared with $2.71 per share a year ago.

On average, 17 analysts polled by Thomson Reuters estimated earnings of $2.75 per share for the quarter. Analysts' estimates typically exclude special items.

The company's revenues for the quarter increased 19 percent to $44.92 billion from $37.83 billion in the prior year.

Fourteen analysts had a consensus revenue estimate of $45.04 billion for the quarter.

For the full year 2016, the company expects adjusted earnings of $12.20 to $12.70 per share, while analysts expect $12.57 per share.

***

37. Vivint Solar (VSLR)

Q1 net income was $12.15 million or $0.11 per share vs $7.04 million or $0.09 per share a year ago.

Q1 non-GAAP net loss was $59.98 million or $0.57 per share vs net loss of $36.54 million or $0.49 per share a year ago.

Q1 revenue was $9.55 million vs $3.51 million a year ago.

Q2 Outlook

Total Revenue to be in the range of $14 million - $15 million.

***

38.Netlist, Inc. (NLST)

Q1 Net loss was ($6.5) million, or ($0.14) per share, compared to a net loss in the prior year period of ($2.0) million, or ($0.05) per share.

Q1 Revenues were $2.1 million, compared to $7.0 million a year ago.

***

39.Dermira, Inc. (DERM)

Q1 net loss was $14.0 million or $0.57 per share compared with a net loss of $8.5 million or $9.56 per share for the same period a year ago.

***

40.CafePress Inc. (PRSS)

Q1 net loss from continuing operations was $(3.1) million, or $(0.18) per share compared to a net loss of $(6.4) million, or $(0.37) per share a year ago.

Q1 Non-GAAP net loss from continuing operations was $(2.0) million, or $(0.12) per share compared to a non-GAAP net loss of $(3.1) million, or $(0.18) per share a year ago.

Q1 Net revenues totaled $27.4 million, compared to $30.9 million in the first quarter of 2014.

***

41.Ardelyx, Inc. (ARDX)

Net loss for the first quarter of 2015 was $3.5 million, or $0.19 per share, compared to a net loss of $3.1 million, or $2.44 per share for the first quarter of 2014.

Q1 revenue was $5.88 million vs $8.55 million a year ago.

***

42.Vuzix Corporation (VUZI)

Q1 net loss was ($5.09) million versus a net income of $1.51 million for the same period a year ago.

Q1 revenue was $809,155 as compared to $798,418 for the same period a year ago.

***

43.TubeMogul, Inc. (TUBE)

Q1 Net loss was $(7.1) million or $0.24 per share compared to a net loss of $(0.8) million or $0.11 per share a year ago.

Q1 Revenue was $30.3 million, an increase of 38% compared to $22.0 million a year ago.

Q2 Outlook

Revenue to be in the range of $38 million to $40 million

FY Outlook

Revenue to be in the range of $149 million to $157 million

***

44.Electromed, Inc. (ELMD)

The company reported net income of $37,000, or $0.00 per share, for the third quarter of fiscal 2015, compared to a net loss of $1,004,000, or ($0.12) per share, for the same period of fiscal 2014.

Net revenues for the third quarter of fiscal 2015 rose approximately 15% to $4.56 million, compared to $3.96 million in the same quarter of fiscal 2014.

***

45. Parsley Energy, Inc. (PE)

Q1 net loss was $17.02 million or $0.17 per share vs net income of $1.98 million a year ago.

Adjusted net loss for the first quarter was $9.8 million, or $0.07 per share.

Revenue for the first quarter was $55.2 million vs $57.73 million a year ago.

***

46.Natural Alternatives International, Inc. (NAII)

Q3 net income was $788000 or $0.12 per share vs $622000 or $0.09 per share a year ago.

Q3 Net sales increased 2.5% to $19.61 million from $19.13 million recorded in the comparable prior year period.

***

47.Zillow Group, Inc. (Z)

Net loss for the first quarter was $58.4 million or $1.19 per share, compared to a net loss of $6.3 million or $0.16 per share for the year-ago quarter.

Excluding share-based compensation expense as well as acquisition and restructuring costs, adjusted net income for the first quarter was $2.2 million or $0.05 per share, compared to $873,000 or $0.02 per share in the prior year quarter.

Pro forma net loss for the first quarter was $17.9 million or $0.31 per share, compared to pro forma net loss of $23.8 million or $0.42 per share in the same quarter last year.

Revenue for the first quarter surged to $127.27 million from $66.24 million a year ago. Pro forma revenue for the quarter increased 35% to $162.5 million from $120.7 million last year.

Zillow reaffirmed its full-year 2015 pro forma revenue outlook of $690 million, which includes Market Leader's expected revenue of $40 million. Analysts currently expect the company to post revenue of $669.84 million for the first quarter.

***

48.The Hackett Group, Inc. (HCKT)

Q1 net income was $3.01 million or $0.10 per share vs $405000 or $0.01 per share a year ago.

Q1 non-GAAP net income was $4.81 million or $0.16 per share vs $2.32 million or $0.08 per share a year ago; Consensus $0.14.

First quarter 2015 revenue increased 11%, to $61.0 million, as compared to $54.9 million for the same period in 2014.

***

49.ADMA Biologics, Inc. (ADMA)

The consolidated net loss for the first quarter was $3.6 million, or $(0.37) per share, as compared to a consolidated net loss of $5.9 million, or ($0.64) per share a year ago.

Q1 revenue was $1.50 million vs $1.56 million a year ago.

***

50.Good Times Restaurants Inc. (GTIM)

Net Loss for the second quarter decreased to $435,000 or $0.05 per share from $509,000 or $0.10 per share last year.

Q2 revenue was $8.71 million vs $6.09 million a year ago.

***

51.Luxfer Group (LXFR)

Q1 net loss was $0.5 million or $0.02 per share vs net income of $7.2 million or $0.27 per share a year ago.

Q1 adjusted net income was $6.9 million or $0.25 per share vs $8 million or $0.28 per share a year ago; Consensus $0.24.

Q1 revenue was $116.9 million vs $123.3 million a year ago.

***

52. Homeinns Hotel Group (HMIN)

Net loss attributable to ordinary shareholders was RMB 37.6 million (US$6.1 million) for the first quarter of 2015, compared with net income of RMB 74.9 million for the first quarter of 2014.

Adjusted net income attributable to ordinary shareholders was RMB 2.0 million (US$0.3 million) for the first quarter of 2015, a decrease of 93.9% year over year.

Total revenues were RMB 1.47 billion (US$237.2 million) for the first quarter of 2015 vs RMB 1.47 milion a year ago.

***